Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non Operating Income (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Other Non Operating Income over the past 16 years, most recently at $171000.0 for Q2 2025.

  • Quarterly results put Other Non Operating Income at $171000.0 for Q2 2025, up 115.52% from a year ago — trailing twelve months through May 2025 was -$3000.0 (up 99.9% YoY), and the annual figure for FY2025 was -$3000.0, up 99.9%.
  • Other Non Operating Income for Q2 2025 was $171000.0 at Lifecore Biomedical, Inc. \De\, down from $333000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for LFCR hit a ceiling of $9.9 million in Q2 2021 and a floor of -$23.4 million in Q2 2023.
  • Median Other Non Operating Income over the past 5 years was -$62000.0 (2021), compared with a mean of -$877444.4.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 3957.03% in 2021 and later plummeted 19905.08% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Other Non Operating Income stood at $330000.0 in 2021, then plummeted by 171.82% to -$237000.0 in 2022, then crashed by 308.02% to -$967000.0 in 2023, then surged by 68.56% to -$304000.0 in 2024, then skyrocketed by 156.25% to $171000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $171000.0 (Q2 2025), $333000.0 (Q1 2025), and -$304000.0 (Q4 2024) per Business Quant data.